Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT07669194 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma (DLBCL)

Interventions

DRUG: Glofitamab combined with selinexor

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]